Structure

Physi-Chem Properties

Molecular Weight:  496.27
Volume:  495.229
LogP:  1.337
LogD:  1.387
LogS:  -3.375
# Rotatable Bonds:  5
TPSA:  160.07
# H-Bond Aceptor:  9
# H-Bond Donor:  7
# Rings:  4
# Heavy Atoms:  9

MedChem Properties

QED Drug-Likeness Score:  0.311
Synthetic Accessibility Score:  4.794
Fsp3:  0.769
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  1
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.881
MDCK Permeability:  9.016066542244516e-06
Pgp-inhibitor:  0.14
Pgp-substrate:  0.994
Human Intestinal Absorption (HIA):  0.329
20% Bioavailability (F20%):  0.006
30% Bioavailability (F30%):  0.015

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.165
Plasma Protein Binding (PPB):  73.07506561279297%
Volume Distribution (VD):  0.352
Pgp-substrate:  20.63654136657715%

ADMET: Metabolism

CYP1A2-inhibitor:  0.022
CYP1A2-substrate:  0.08
CYP2C19-inhibitor:  0.003
CYP2C19-substrate:  0.673
CYP2C9-inhibitor:  0.001
CYP2C9-substrate:  0.275
CYP2D6-inhibitor:  0.004
CYP2D6-substrate:  0.186
CYP3A4-inhibitor:  0.009
CYP3A4-substrate:  0.077

ADMET: Excretion

Clearance (CL):  3.496
Half-life (T1/2):  0.584

ADMET: Toxicity

hERG Blockers:  0.049
Human Hepatotoxicity (H-HT):  0.32
Drug-inuced Liver Injury (DILI):  0.013
AMES Toxicity:  0.196
Rat Oral Acute Toxicity:  0.354
Maximum Recommended Daily Dose:  0.968
Skin Sensitization:  0.826
Carcinogencity:  0.037
Eye Corrosion:  0.003
Eye Irritation:  0.01
Respiratory Toxicity:  0.894

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC183380

Natural Product ID:  NPC183380
Common Name*:   (2S,3R,4S,5S,6R)-2-[[(4Bs,7S,8Ar)-4,7-Dihydroxy-2-[(2S)-1-Hydroxypropan-2-Yl]-4B,8,8-Trimethyl-5,6,7,8A,9,10-Hexahydrophenanthren-3-Yl]Oxy]-6-(Hydroxymethyl)Oxane-3,4,5-Triol
IUPAC Name:   (2S,3R,4S,5S,6R)-2-[[(4bS,7S,8aR)-4,7-dihydroxy-2-[(2S)-1-hydroxypropan-2-yl]-4b,8,8-trimethyl-5,6,7,8a,9,10-hexahydrophenanthren-3-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol
Synonyms:  
Standard InCHIKey:  IACPYMAYLYRWCN-VXAYKVKJSA-N
Standard InCHI:  InChI=1S/C26H40O9/c1-12(10-27)14-9-13-5-6-16-25(2,3)17(29)7-8-26(16,4)18(13)20(31)23(14)35-24-22(33)21(32)19(30)15(11-28)34-24/h9,12,15-17,19,21-22,24,27-33H,5-8,10-11H2,1-4H3/t12-,15-,16+,17+,19-,21+,22-,24+,26+/m1/s1
SMILES:  C[C@H](CO)c1cc2CC[C@H]3C(C)(C)[C@H](CC[C@]3(C)c2c(c1O[C@H]1[C@@H]([C@H]([C@@H]([C@@H](CO)O1)O)O)O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL523355
PubChem CID:   24879399
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0002049] Terpene glycosides
          • [CHEMONTID:0001755] Diterpene glycosides

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO20879 Clerodendrum bungei Species Lamiaceae Eukaryota n.a. n.a. n.a. PMID[18348535]
NPO20879 Clerodendrum bungei Species Lamiaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO20879 Clerodendrum bungei Species Lamiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT319 Cell Line B16 Mus musculus IC50 > 10000.0 nM PMID[549590]
NPT2511 Cell Line HGC-27 Homo sapiens IC50 > 10000.0 nM PMID[549590]
NPT71 Cell Line HEK293 Homo sapiens IC50 > 10000.0 nM PMID[549590]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC183380 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9793 High Similarity NPC200645
0.9793 High Similarity NPC106669
0.9793 High Similarity NPC475227
0.9583 High Similarity NPC179809
0.9577 High Similarity NPC164183
0.9577 High Similarity NPC133251
0.9384 High Similarity NPC44452
0.9384 High Similarity NPC474893
0.9384 High Similarity NPC475940
0.9384 High Similarity NPC220006
0.9384 High Similarity NPC181452
0.9315 High Similarity NPC291326
0.9315 High Similarity NPC474940
0.9315 High Similarity NPC474795
0.9315 High Similarity NPC303013
0.9315 High Similarity NPC474834
0.9315 High Similarity NPC117788
0.9315 High Similarity NPC159697
0.9315 High Similarity NPC290902
0.9315 High Similarity NPC474856
0.9315 High Similarity NPC130959
0.9241 High Similarity NPC286245
0.9241 High Similarity NPC272619
0.9221 High Similarity NPC25889
0.9189 High Similarity NPC225815
0.9189 High Similarity NPC469706
0.9189 High Similarity NPC182368
0.9189 High Similarity NPC145979
0.9189 High Similarity NPC260781
0.9189 High Similarity NPC9933
0.9189 High Similarity NPC214326
0.9189 High Similarity NPC218041
0.9189 High Similarity NPC185955
0.9189 High Similarity NPC469707
0.9172 High Similarity NPC253015
0.9172 High Similarity NPC471065
0.9116 High Similarity NPC213074
0.9116 High Similarity NPC275284
0.9116 High Similarity NPC193473
0.9116 High Similarity NPC224674
0.9116 High Similarity NPC114505
0.9116 High Similarity NPC15956
0.9116 High Similarity NPC31325
0.9085 High Similarity NPC68292
0.9067 High Similarity NPC21902
0.9067 High Similarity NPC474442
0.898 High Similarity NPC43508
0.898 High Similarity NPC476301
0.8933 High Similarity NPC472710
0.8933 High Similarity NPC472709
0.8933 High Similarity NPC98624
0.8912 High Similarity NPC79429
0.8912 High Similarity NPC217635
0.8912 High Similarity NPC471667
0.8874 High Similarity NPC2745
0.8873 High Similarity NPC227719
0.8844 High Similarity NPC470950
0.8844 High Similarity NPC185307
0.8816 High Similarity NPC157783
0.8808 High Similarity NPC195561
0.8808 High Similarity NPC158784
0.8784 High Similarity NPC283995
0.8784 High Similarity NPC470235
0.8784 High Similarity NPC129417
0.8776 High Similarity NPC476356
0.8776 High Similarity NPC253878
0.8767 High Similarity NPC106944
0.8759 High Similarity NPC470413
0.8759 High Similarity NPC138738
0.8758 High Similarity NPC78809
0.875 High Similarity NPC302915
0.8732 High Similarity NPC312341
0.8725 High Similarity NPC38041
0.8725 High Similarity NPC475096
0.8725 High Similarity NPC277867
0.8725 High Similarity NPC161700
0.8725 High Similarity NPC279298
0.8725 High Similarity NPC22150
0.8718 High Similarity NPC478269
0.8716 High Similarity NPC46092
0.8716 High Similarity NPC113680
0.8716 High Similarity NPC278961
0.8707 High Similarity NPC471414
0.8707 High Similarity NPC472711
0.8693 High Similarity NPC325860
0.869 High Similarity NPC52277
0.869 High Similarity NPC199459
0.869 High Similarity NPC177035
0.8675 High Similarity NPC212142
0.8675 High Similarity NPC270751
0.8675 High Similarity NPC473876
0.8671 High Similarity NPC59239
0.8667 High Similarity NPC99515
0.8667 High Similarity NPC112861
0.8667 High Similarity NPC125755
0.8667 High Similarity NPC190714
0.8658 High Similarity NPC473845
0.8649 High Similarity NPC48309
0.8649 High Similarity NPC5262
0.8649 High Similarity NPC60249
0.8649 High Similarity NPC472714
0.863 High Similarity NPC304152
0.8609 High Similarity NPC474397
0.8609 High Similarity NPC39657
0.8609 High Similarity NPC227902
0.8608 High Similarity NPC478267
0.86 High Similarity NPC90645
0.86 High Similarity NPC18979
0.86 High Similarity NPC472457
0.8598 High Similarity NPC475054
0.8591 High Similarity NPC37793
0.8591 High Similarity NPC477898
0.859 High Similarity NPC228357
0.8581 High Similarity NPC76871
0.8571 High Similarity NPC476452
0.8562 High Similarity NPC475224
0.8553 High Similarity NPC130449
0.8553 High Similarity NPC175976
0.8553 High Similarity NPC95990
0.8553 High Similarity NPC248132
0.8552 High Similarity NPC476411
0.8552 High Similarity NPC187194
0.8552 High Similarity NPC35731
0.8544 High Similarity NPC1253
0.8544 High Similarity NPC100936
0.8543 High Similarity NPC233980
0.8533 High Similarity NPC168579
0.8533 High Similarity NPC472712
0.8533 High Similarity NPC473108
0.8533 High Similarity NPC138227
0.8533 High Similarity NPC471063
0.8533 High Similarity NPC118385
0.8533 High Similarity NPC472713
0.8533 High Similarity NPC84181
0.8533 High Similarity NPC187774
0.8533 High Similarity NPC25292
0.8533 High Similarity NPC469313
0.8533 High Similarity NPC473045
0.8533 High Similarity NPC76176
0.8533 High Similarity NPC473046
0.8531 High Similarity NPC99795
0.8523 High Similarity NPC189115
0.8523 High Similarity NPC469559
0.8523 High Similarity NPC246947
0.8523 High Similarity NPC475084
0.8521 High Similarity NPC201069
0.8497 Intermediate Similarity NPC286235
0.8497 Intermediate Similarity NPC51328
0.8497 Intermediate Similarity NPC55158
0.8493 Intermediate Similarity NPC79957
0.8487 Intermediate Similarity NPC15538
0.8487 Intermediate Similarity NPC473480
0.8481 Intermediate Similarity NPC185231
0.8472 Intermediate Similarity NPC65942
0.8472 Intermediate Similarity NPC248307
0.8467 Intermediate Similarity NPC472451
0.8467 Intermediate Similarity NPC473044
0.8456 Intermediate Similarity NPC210192
0.8456 Intermediate Similarity NPC35216
0.8456 Intermediate Similarity NPC265075
0.8456 Intermediate Similarity NPC469661
0.8452 Intermediate Similarity NPC134911
0.8452 Intermediate Similarity NPC46283
0.8452 Intermediate Similarity NPC322899
0.8452 Intermediate Similarity NPC160196
0.8452 Intermediate Similarity NPC469944
0.8452 Intermediate Similarity NPC44192
0.8452 Intermediate Similarity NPC226108
0.8452 Intermediate Similarity NPC302610
0.8452 Intermediate Similarity NPC272552
0.8446 Intermediate Similarity NPC230124
0.8446 Intermediate Similarity NPC114171
0.8446 Intermediate Similarity NPC6300
0.8442 Intermediate Similarity NPC477612
0.8442 Intermediate Similarity NPC24425
0.8435 Intermediate Similarity NPC29799
0.8435 Intermediate Similarity NPC263367
0.8435 Intermediate Similarity NPC10737
0.8435 Intermediate Similarity NPC54743
0.8435 Intermediate Similarity NPC156502
0.8435 Intermediate Similarity NPC477939
0.8435 Intermediate Similarity NPC209985
0.8435 Intermediate Similarity NPC177160
0.8431 Intermediate Similarity NPC226153
0.8431 Intermediate Similarity NPC304048
0.8431 Intermediate Similarity NPC280945
0.8425 Intermediate Similarity NPC478085
0.8425 Intermediate Similarity NPC311256
0.8425 Intermediate Similarity NPC87696
0.8421 Intermediate Similarity NPC471608
0.8421 Intermediate Similarity NPC260397
0.8421 Intermediate Similarity NPC205796
0.8421 Intermediate Similarity NPC276753
0.8421 Intermediate Similarity NPC112251
0.8414 Intermediate Similarity NPC321086
0.8411 Intermediate Similarity NPC50250
0.8403 Intermediate Similarity NPC80600
0.8403 Intermediate Similarity NPC472024
0.84 Intermediate Similarity NPC302506
0.84 Intermediate Similarity NPC186033

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC183380 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9366 High Similarity NPD6674 Discontinued
0.8232 Intermediate Similarity NPD7228 Approved
0.8041 Intermediate Similarity NPD3619 Clinical (unspecified phase)
0.8041 Intermediate Similarity NPD3620 Phase 2
0.8025 Intermediate Similarity NPD6234 Discontinued
0.7937 Intermediate Similarity NPD37 Approved
0.7919 Intermediate Similarity NPD1613 Approved
0.7919 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7901 Intermediate Similarity NPD4965 Approved
0.7901 Intermediate Similarity NPD4967 Phase 2
0.7901 Intermediate Similarity NPD4966 Approved
0.7857 Intermediate Similarity NPD5698 Clinical (unspecified phase)
0.7843 Intermediate Similarity NPD7266 Discontinued
0.7799 Intermediate Similarity NPD1653 Approved
0.7785 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7719 Intermediate Similarity NPD7240 Approved
0.7718 Intermediate Similarity NPD3027 Phase 3
0.7706 Intermediate Similarity NPD7074 Phase 3
0.7703 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7669 Intermediate Similarity NPD8455 Phase 2
0.7667 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7655 Intermediate Similarity NPD3705 Approved
0.7655 Intermediate Similarity NPD1091 Approved
0.7651 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7647 Intermediate Similarity NPD7054 Approved
0.7632 Intermediate Similarity NPD5735 Approved
0.763 Intermediate Similarity NPD8313 Approved
0.763 Intermediate Similarity NPD8312 Approved
0.7605 Intermediate Similarity NPD7199 Phase 2
0.7602 Intermediate Similarity NPD7472 Approved
0.7566 Intermediate Similarity NPD4060 Phase 1
0.7544 Intermediate Similarity NPD5844 Phase 1
0.7533 Intermediate Similarity NPD4908 Phase 1
0.75 Intermediate Similarity NPD8651 Approved
0.75 Intermediate Similarity NPD6696 Suspended
0.75 Intermediate Similarity NPD8127 Discontinued
0.7483 Intermediate Similarity NPD4625 Phase 3
0.7471 Intermediate Similarity NPD2489 Approved
0.7471 Intermediate Similarity NPD27 Approved
0.7467 Intermediate Similarity NPD2861 Phase 2
0.7458 Intermediate Similarity NPD7906 Approved
0.7456 Intermediate Similarity NPD3051 Approved
0.7443 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7429 Intermediate Similarity NPD7310 Approved
0.7429 Intermediate Similarity NPD7311 Approved
0.7429 Intermediate Similarity NPD7313 Approved
0.7429 Intermediate Similarity NPD7312 Approved
0.7416 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7414 Intermediate Similarity NPD7251 Discontinued
0.7412 Intermediate Similarity NPD2969 Approved
0.7412 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7412 Intermediate Similarity NPD2970 Approved
0.7401 Intermediate Similarity NPD4663 Approved
0.74 Intermediate Similarity NPD6917 Clinical (unspecified phase)
0.7397 Intermediate Similarity NPD5126 Approved
0.7397 Intermediate Similarity NPD5125 Phase 3
0.7391 Intermediate Similarity NPD4160 Clinical (unspecified phase)
0.7389 Intermediate Similarity NPD5762 Approved
0.7389 Intermediate Similarity NPD5763 Approved
0.7386 Intermediate Similarity NPD7309 Approved
0.7384 Intermediate Similarity NPD3818 Discontinued
0.7377 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7371 Intermediate Similarity NPD7808 Phase 3
0.7365 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7356 Intermediate Similarity NPD6797 Phase 2
0.7338 Intermediate Similarity NPD4140 Approved
0.733 Intermediate Similarity NPD4577 Approved
0.733 Intermediate Similarity NPD4578 Approved
0.7329 Intermediate Similarity NPD1357 Approved
0.7315 Intermediate Similarity NPD4749 Approved
0.7315 Intermediate Similarity NPD5327 Phase 3
0.7314 Intermediate Similarity NPD6559 Discontinued
0.7308 Intermediate Similarity NPD7097 Phase 1
0.7292 Intermediate Similarity NPD7157 Approved
0.7284 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7273 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7267 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7267 Intermediate Similarity NPD5058 Phase 3
0.7267 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7267 Intermediate Similarity NPD6166 Phase 2
0.7246 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7241 Intermediate Similarity NPD7340 Approved
0.7241 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7238 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7225 Intermediate Similarity NPD7473 Discontinued
0.7219 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7219 Intermediate Similarity NPD3094 Phase 2
0.7219 Intermediate Similarity NPD7680 Approved
0.7216 Intermediate Similarity NPD7685 Pre-registration
0.7215 Intermediate Similarity NPD6099 Approved
0.7215 Intermediate Similarity NPD6100 Approved
0.7186 Intermediate Similarity NPD1934 Approved
0.7181 Intermediate Similarity NPD1610 Phase 2
0.7179 Intermediate Similarity NPD3657 Discovery
0.7152 Intermediate Similarity NPD4108 Discontinued
0.7151 Intermediate Similarity NPD6232 Discontinued
0.7143 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7134 Intermediate Similarity NPD4097 Suspended
0.7134 Intermediate Similarity NPD6353 Approved
0.7108 Intermediate Similarity NPD7458 Discontinued
0.7097 Intermediate Similarity NPD7985 Registered
0.7095 Intermediate Similarity NPD7090 Clinical (unspecified phase)
0.7093 Intermediate Similarity NPD6959 Discontinued
0.7089 Intermediate Similarity NPD4538 Approved
0.7089 Intermediate Similarity NPD4536 Approved
0.7089 Intermediate Similarity NPD4537 Clinical (unspecified phase)
0.7086 Intermediate Similarity NPD3600 Clinical (unspecified phase)
0.7072 Intermediate Similarity NPD6841 Approved
0.7072 Intermediate Similarity NPD6843 Phase 3
0.7072 Intermediate Similarity NPD6842 Approved
0.707 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.707 Intermediate Similarity NPD5124 Phase 1
0.7067 Intermediate Similarity NPD3092 Approved
0.7063 Intermediate Similarity NPD2029 Clinical (unspecified phase)
0.7052 Intermediate Similarity NPD6071 Discontinued
0.7052 Intermediate Similarity NPD3787 Discontinued
0.7041 Intermediate Similarity NPD1465 Phase 2
0.7037 Intermediate Similarity NPD4109 Clinical (unspecified phase)
0.7037 Intermediate Similarity NPD8166 Discontinued
0.7037 Intermediate Similarity NPD7982 Clinical (unspecified phase)
0.7037 Intermediate Similarity NPD4110 Phase 3
0.7037 Intermediate Similarity NPD4628 Phase 3
0.7034 Intermediate Similarity NPD5283 Phase 1
0.7034 Intermediate Similarity NPD1398 Phase 1
0.7032 Intermediate Similarity NPD7095 Approved
0.703 Intermediate Similarity NPD5261 Clinical (unspecified phase)
0.7018 Intermediate Similarity NPD7831 Phase 2
0.7018 Intermediate Similarity NPD7833 Phase 2
0.7018 Intermediate Similarity NPD7832 Clinical (unspecified phase)
0.7014 Intermediate Similarity NPD228 Approved
0.7012 Intermediate Similarity NPD7040 Clinical (unspecified phase)
0.7012 Intermediate Similarity NPD7041 Phase 2
0.7012 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7006 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD2560 Approved
0.7 Intermediate Similarity NPD2563 Approved
0.6994 Remote Similarity NPD2677 Approved
0.6971 Remote Similarity NPD4481 Phase 3
0.697 Remote Similarity NPD7446 Clinical (unspecified phase)
0.697 Remote Similarity NPD7422 Clinical (unspecified phase)
0.6966 Remote Similarity NPD7993 Clinical (unspecified phase)
0.6966 Remote Similarity NPD7843 Approved
0.6964 Remote Similarity NPD7028 Phase 2
0.6939 Remote Similarity NPD6671 Approved
0.6937 Remote Similarity NPD5588 Approved
0.6937 Remote Similarity NPD5960 Phase 3
0.6936 Remote Similarity NPD4666 Phase 3
0.6933 Remote Similarity NPD4626 Approved
0.6919 Remote Similarity NPD7975 Clinical (unspecified phase)
0.6913 Remote Similarity NPD3091 Approved
0.6902 Remote Similarity NPD2488 Approved
0.6902 Remote Similarity NPD2490 Approved
0.6901 Remote Similarity NPD8443 Clinical (unspecified phase)
0.6895 Remote Similarity NPD6823 Phase 2
0.6893 Remote Similarity NPD3751 Discontinued
0.6879 Remote Similarity NPD5709 Phase 3
0.6878 Remote Similarity NPD6778 Approved
0.6878 Remote Similarity NPD6781 Approved
0.6878 Remote Similarity NPD6776 Approved
0.6878 Remote Similarity NPD6779 Approved
0.6878 Remote Similarity NPD6780 Approved
0.6878 Remote Similarity NPD6782 Approved
0.6878 Remote Similarity NPD6777 Approved
0.6872 Remote Similarity NPD7782 Clinical (unspecified phase)
0.6872 Remote Similarity NPD7783 Phase 2
0.6867 Remote Similarity NPD5691 Approved
0.6864 Remote Similarity NPD4380 Phase 2
0.6859 Remote Similarity NPD7435 Discontinued
0.6856 Remote Similarity NPD8151 Discontinued
0.6855 Remote Similarity NPD6355 Discontinued
0.6852 Remote Similarity NPD1375 Discontinued
0.6842 Remote Similarity NPD2494 Approved
0.6842 Remote Similarity NPD7819 Suspended
0.6842 Remote Similarity NPD2977 Approved
0.6842 Remote Similarity NPD2493 Approved
0.6842 Remote Similarity NPD2801 Approved
0.6842 Remote Similarity NPD5929 Approved
0.6842 Remote Similarity NPD2978 Approved
0.6839 Remote Similarity NPD4624 Approved
0.6839 Remote Similarity NPD5494 Approved
0.6832 Remote Similarity NPD6028 Clinical (unspecified phase)
0.6832 Remote Similarity NPD6029 Clinical (unspecified phase)
0.6829 Remote Similarity NPD6331 Phase 2
0.6826 Remote Similarity NPD6273 Approved
0.6823 Remote Similarity NPD4582 Approved
0.6823 Remote Similarity NPD4583 Approved
0.6821 Remote Similarity NPD7075 Discontinued
0.6813 Remote Similarity NPD8053 Approved
0.6813 Remote Similarity NPD8054 Approved
0.6806 Remote Similarity NPD2684 Approved
0.68 Remote Similarity NPD7741 Discontinued
0.68 Remote Similarity NPD1548 Phase 1
0.6795 Remote Similarity NPD3018 Phase 2
0.6795 Remote Similarity NPD5736 Approved
0.6792 Remote Similarity NPD1558 Phase 1
0.679 Remote Similarity NPD2438 Suspended
0.6788 Remote Similarity NPD5084 Clinical (unspecified phase)
0.6784 Remote Similarity NPD5722 Discontinued
0.6772 Remote Similarity NPD1699 Clinical (unspecified phase)
0.6772 Remote Similarity NPD6798 Discontinued

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data